These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22223089)

  • 41. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
    Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
    Dong F; Lou D
    Mol Vis; 2012; 18():537-46. PubMed ID: 22419847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant microRNA expression in tumor mycosis fungoides.
    Papadavid E; Braoudaki M; Bourdakou M; Lykoudi A; Nikolaou V; Tounta G; Ekonomidi A; Athanasiadis E; Spyrou G; Antoniou C; Kitsiou-Tzeli S; Rigopoulos D; Kolialexi A
    Tumour Biol; 2016 Nov; 37(11):14667-14675. PubMed ID: 27623940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circular RNA circ_0079593 enhances malignant melanoma progression by the regulation of the miR-573/ABHD2 axis.
    Zhao F; Jia Z; Feng Y; Li Z; Feng J
    J Dermatol Sci; 2021 Apr; 102(1):7-15. PubMed ID: 33648800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
    Mishra RR; Kneitz S; Schartl M
    Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.
    Sun Z; Zhou S; Tang J; Ye T; Li J; Liu D; Zhou J; Wang J; Rosie Xing H
    EBioMedicine; 2018 Nov; 37():47-55. PubMed ID: 30301603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.
    Margue C; Philippidou D; Reinsbach SE; Schmitt M; Behrmann I; Kreis S
    PLoS One; 2013; 8(9):e73473. PubMed ID: 24039954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma.
    Dika E; Riefolo M; Porcellini E; Broseghini E; Ribero S; Senetta R; Osella-Abate S; Scarfì F; Lambertini M; Veronesi G; Patrizi A; Fanti PA; Ferracin M
    J Invest Dermatol; 2020 Nov; 140(11):2260-2267. PubMed ID: 32275975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Downregulation of miR-125b in metastatic cutaneous malignant melanoma.
    Glud M; Rossing M; Hother C; Holst L; Hastrup N; Nielsen FC; Gniadecki R; Drzewiecki KT
    Melanoma Res; 2010 Dec; 20(6):479-84. PubMed ID: 20827223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator.
    Wang J; Fang Y; Liu YF; Wang X; Wang XL; Wang RY; Meng ZD
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4275-4284. PubMed ID: 31173299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.
    Bhattacharya A; Schmitz U; Raatz Y; Schönherr M; Kottek T; Schauer M; Franz S; Saalbach A; Anderegg U; Wolkenhauer O; Schadendorf D; Simon JC; Magin T; Vera J; Kunz M
    Oncotarget; 2015 Feb; 6(5):2966-80. PubMed ID: 25650662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
    Nguyen T; Kuo C; Nicholl MB; Sim MS; Turner RR; Morton DL; Hoon DS
    Epigenetics; 2011 Mar; 6(3):388-94. PubMed ID: 21081840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule.
    Wang HF; Chen H; Ma MW; Wang JA; Tang TT; Ni LS; Yu JL; Li YZ; Bai BX
    Oncol Rep; 2013 Jul; 30(1):520-6. PubMed ID: 23670160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
    Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
    Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of microRNA miR-126 and miR-200c is associated with prognosis in patients with non-small cell lung cancer.
    Kim MK; Jung SB; Kim JS; Roh MS; Lee JH; Lee EH; Lee HW
    Virchows Arch; 2014 Oct; 465(4):463-71. PubMed ID: 25124149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-431 is a prognostic marker and suppresses cell growth, migration and invasion by targeting NOTCH2 in melanoma.
    Sun YW; Li XH; Wang H; Wu J
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3876-3884. PubMed ID: 31115015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The tumour suppressor, miR-137, inhibits malignant melanoma migration by targetting the TBX3 transcription factor.
    Peres J; Kwesi-Maliepaard EM; Rambow F; Larue L; Prince S
    Cancer Lett; 2017 Oct; 405():111-119. PubMed ID: 28757416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.
    Ibrahim FF; Jamal R; Syafruddin SE; Ab Mutalib NS; Saidin S; MdZin RR; Hossain Mollah MM; Mokhtar NM
    J Ovarian Res; 2015 Aug; 8():56. PubMed ID: 26260454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.
    Laar RV; King S; McCoy R; Saad M; Fereday S; Winship I; Uzzell C; Landgren A
    Biomark Med; 2021 Sep; 15(13):1111-1122. PubMed ID: 34184547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.